Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: NKGen Biotech(NKGN) the EBIT is -4.666 M (+38.77%);the EPS is -0.0404 (+83.86%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B38.77%
----
----
EPS
-0.040483.86%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf